CSF complement proteins are elevated in prodromal to moderate AD patients and are not altered by the anti-tau antibody semorinemab
Preprint in medRxiv (April 2024)
The most recent citing publications are shown below. View all 90 publications that cite this research output on Dimensions.
Preprint in medRxiv (April 2024)
Preprint in medRxiv (April 2024)
Article in Frontiers in Neuroimaging (March 2024)